Caricamento...

An innovative diagnostic strategy for the detection of rare molecular targets to select cancer patients for tumor-agnostic treatments

Targeted therapies are playing an increasing role in oncology. Among them, particular attention is nowadays reserved to histology-agnostic treatments. Rare molecular alterations affecting different neoplastic forms, such as Microsatellite Instability (MSI), Neurotropic Tyrosine Receptor Kinase (NTRK...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Marchetti, Antonio, Di Lorito, Alessia, Felicioni, Lara, Buttitta, Fiamma
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2019
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6916754/
https://ncbi.nlm.nih.gov/pubmed/31857850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27343
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !